Serum measurement of osteoprotegerin--clinical relevance and potential applications.
Hofbauer
L C
LC
Division of Gastroenterology, Endocrinology and Metabolism, Department of Medicine, Philipps-University, D-35033 Marburg, Germany. hofbauer@post.med.uni-marburg.de
Schoppet
M
M
D000375:Aging; D015519:Bone Density; D002352:Carrier Proteins / Q000378:metabolism; D004700:Endocrine System Diseases / Q000097:blood; D005260:Female; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000097:blood; D008297:Male; D008562:Membrane Glycoproteins / Q000378:metabolism; D053244:Osteoprotegerin; D017698:Postmenopause; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D018160:Receptors, Cytoplasmic and Nuclear / Q000097:blood*; D018124:Receptors, Tumor Necrosis Factor
D002352:Carrier Proteins; D006023:Glycoproteins; D008562:Membrane Glycoproteins; D053244:Osteoprotegerin; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C505686:TNFRSF11A protein, human; C506030:TNFRSF11B protein, human; C505688:TNFSF11 protein, human